Gland Pharma Limited

Gland Pharma Limitedverified

GLAND.NS

Price:

$1750

Market Cap:

$288.32B

Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analg...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2020-11-20

Stock Exchange

NSE

Ticker

GLAND.NS

The Enterprise Value as of December 2025 (TTM) for Gland Pharma Limited (GLAND.NS) is 264.31B

According to Gland Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 264.31B. This represents a change of -6.69% compared to the average of 283.26B of the last 4 quarters.

Gland Pharma Limited (GLAND.NS) Historical Enterprise Value (quarterly & annually)

How has GLAND.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Gland Pharma Limited over the last ten years is 306.66B. The current 264.31B Enterprise Value has changed 8.52% with respect to the historical average. Over the past ten years (40 quarters), GLAND.NS's Enterprise Value was at its highest in in the December 2021 quarter at 664.14B. The Enterprise Value was at its lowest in in the December 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

306.66B

Median

279.65B

Minimum

189.80B

Maximum

535.37B

Gland Pharma Limited (GLAND.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Gland Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 57.50%

Maximum Annual Enterprise Value = 535.37B

Minimum Annual Increase = -64.55%

Minimum Annual Enterprise Value = 189.80B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025233.52B-21.89%
2024298.95B57.50%
2023189.80B-64.55%
2022535.37B38.20%
2021387.38B38.20%
2020280.30B0.23%
2019279.65B0.49%
2018278.28B0.58%

Gland Pharma Limited (GLAND.NS) Average Enterprise Value

How has GLAND.NS Enterprise Value performed in the past?

The current Enterprise Value of Gland Pharma Limited (GLAND.NS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

240.76B

5-year avg

329.00B

10-year avg

306.66B

Gland Pharma Limited (GLAND.NS) Enterprise Value vs. Peers

How is GLAND.NS’s Enterprise Value compared to its peers?

Gland Pharma Limited’s Enterprise Value is less than Ipca Laboratories Limited (377.26B), less than Ipca Laboratories Limited (377.26B), less than Ajanta Pharma Limited (331.25B), less than Ajanta Pharma Limited (331.25B), greater than Pfizer Limited (227.35B), greater than Pfizer Limited (227.35B), less than J. B. Chemicals & Pharmaceuticals Limited (285.98B), less than Global Health Limited (316.22B), less than J. B. Chemicals & Pharmaceuticals Limited (285.98B), less than Global Health Limited (316.22B),

Build a custom stock screener for Gland Pharma Limited (GLAND.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gland Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gland Pharma Limited (GLAND.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gland Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Gland Pharma Limited's Enterprise Value?

What is the highest Enterprise Value for Gland Pharma Limited (GLAND.NS)?

What is the 3-year average Enterprise Value for Gland Pharma Limited (GLAND.NS)?

What is the 5-year average Enterprise Value for Gland Pharma Limited (GLAND.NS)?

How does the current Enterprise Value for Gland Pharma Limited (GLAND.NS) compare to its historical average?